Every story in this section, newest first — page 290 of 373.
Vontier (NYSE:VNT) today revealed fourth-quarter and full-year 2025 results that exceeded Wall Street estimates, propelled by a rapid shift toward digital services in the mobility ecosystem.
Zebra Technologies (NASDAQ:ZBRA) shares jumped nearly 9% in early trading Thursday after the company paired a fourth-quarter revenue beat with an optimistic 2026 forecast and a massive new $1 billion share repurchase authorization.
Utz Brands (NYSE:UTZ) reported fourth-quarter results defined by significant operational efficiency and a sharp increase in profitability, even as the broader salty snack category faced a muted demand environment.
Entergy (NYSE:ETR) reported a significant jump in annual profitability for 2025, as the utility successfully leveraged rising industrial demand and a series of favorable regulatory outcomes across its four-state service territory.
EverQuote (NASDAQ:EVER) saw its stock tumble 10.9% on Wednesday, as the launch of a first-of-its-kind artificial intelligence tool from rival Insurify sparked a sell-off across the online insurance brokerage landscape.
Hyperliquid Strategies (NASDAQ:PURR) today reported financial results for the quarter and six months ended December 31, 2025, following its successful listing on NASDAQ on December 2, 2025.
Oatly Group (NASDAQ:OTLY) shares jumped in early trading Wednesday after the Swedish oat-milk pioneer reported its first full year of positive adjusted EBITDA, signaling a successful pivot from breakneck expansion to disciplined, profitable growth.
Frontier Group Holdings (NASDAQ:ULCC) posted fourth-quarter earnings that cleared Wall Street estimates, as the ultra-low-cost carrier moves to aggressively "right-size" its fleet following a difficult fiscal year.
Robinhood Markets (NASDAQ:HOOD) saw its shares plunge more than 12% in Wednesday trading, as a significant miss on fourth-quarter revenue overshadowed record annual profits and an earnings-per-share beat.
Upstream Bio (NASDAQ:UPB) announced breakthrough results for its lead candidate, verekitug, in a mid-stage trial that could disrupt the multibillion-dollar biologics market for severe respiratory diseases.
Radware (NASDAQ:RDWR) posted record-breaking financial results for both the fourth quarter and full year 2025, buoyed by an aggressive shift toward cloud-based security and new AI-driven defense platforms.
Generac Holdings (NYSE:GNRC) is betting on a "generational opportunity" in the data center market to drive a 2026 rebound, even as a massive legal settlement and a cooling residential market weighed down its latest quarterly results.
QXO (NYSE:QXO) has struck a definitive agreement to acquire Kodiak Building Partners for approximately $2.25 billion, marking the second major move by billionaire chairman Brad Jacobs to consolidate the fragmented building products distribution industry.
Veru (NASDAQ:VERU) reported a significantly narrowed operating loss for the first fiscal quarter, as the biopharmaceutical firm pivots its resources toward a high-stakes clinical trial for its muscle-preserving obesity treatment.
Parsons (NYSE:PSN) reached a milestone in profitability even as a sharp contraction in its federal business weighed on the top line, reflecting a strategic pivot toward higher-margin infrastructure projects.
NiSource (NYSE:NI) signaled a fundamental shift in its growth trajectory today, reporting record 2025 results alongside a transformative capital plan that hitches the utility’s future to the burgeoning AI and data center sector.
Smurfit Westrock (NYSE:SW) demonstrated the industrial muscle of its recent $11 billion merger, reporting fourth-quarter results that hit internal operational targets despite a softening global demand for cardboard boxes.
Needham, Massachusetts-based SharkNinja (NYSE:SN), a global product design and technology company focused on innovative home appliances, reported strong financial results for the fourth quarter and full year ended December 31, 2025.
New York-based Chimera Investment Corporation (NYSE:CIM) today announced financial results for the fourth quarter and full year ended December 31, 2025.
TotalEnergies (NYSE:TTE) solidified its status as the most efficient player among the global energy majors, reporting an industry-leading 12.6% return on capital for 2025 despite a significant downturn in the global crude market.
Merck (NYSE:MRK) reached a historic milestone in oncology today as the FDA approved KEYTRUDA (pembrolizumab) and its new subcutaneous twin, KEYTRUDA QLEX, for the treatment of platinum-resistant ovarian cancer.
Agilent Technologies (NYSE:A) announced today that the U.S. Food and Drug Administration (FDA) has approved its PD-L1 IHC 22C3 pharmDx as the first and only companion diagnostic to identify first-line patients with epithelial ovarian cancer (EOC) eligible for Merck’s blockbuster immunotherapy, KEYTRUDA.
Kornit Digital (NASDAQ:KRNT) marked a major structural turning point in 2025, successfully transitioning its business from one-time equipment sales to a resilient recurring revenue model.
